{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:17:56Z","timestamp":1792275476502,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.transproceed.2022.10.046","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T07:36:51Z","timestamp":1668411411000},"page":"2584-2588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience"],"prefix":"10.1016","volume":"54","author":[{"given":"Ildik\u00f3","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benj\u00e1min Reg\u0151","family":"Bar\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Mang\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir-Houshang","family":"Shemirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Monostory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Nemes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.10.046_bib0001","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5500\/wjt.v2.i4.51","article-title":"Current state of renal transplant immunosuppression: present and future","volume":"2","author":"Kalluri","year":"2012","journal-title":"World J Transplant"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0002","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1517\/14656566.9.4.635","article-title":"The role of tacrolimus in renal transplantation","volume":"9","author":"Bowman","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0003","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3389\/fgene.2019.00871","article-title":"The impact of CYP3A4*22 on tacrolimus pharmacokinetics and outcome in clinical practice at a single kidney transplant center","volume":"10","author":"Abdel-Kahaar","year":"2019","journal-title":"Front Genet"},{"issue":"Suppl. 3","key":"10.1016\/j.transproceed.2022.10.046_bib0004","first-page":"1666","article-title":"Association of tacrolimus trough level and daily dose ratio with outcomes in a prospective prevalent cohort of kidney transplant recipients","volume":"35","author":"Cseprekal","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41397-020-00179-4","article-title":"Influence of CYP3A polymorphisms on tacrolimus pharmacokinetics in kidney transplant recipients","volume":"21","author":"Hannachi","year":"2021","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/phar.2131","article-title":"Tacrolimus elimination in four patients with a CYP3A5*3\/*3 CYP3A4*22\/*22 genotype combination","volume":"38","author":"Scheibner","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/tpj.2014.38","article-title":"Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies","volume":"15","author":"Rojas","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0008","series-title":"Organ donation and transplantation\u2014current status and future challenges","first-page":"409","article-title":"Metabolic drug interactions with immunosuppressants","author":"Monostory","year":"2018"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0009","doi-asserted-by":"crossref","first-page":"21389","DOI":"10.1038\/s41598-021-00942-y","article-title":"CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients","volume":"11","author":"D\u00e9ri","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/biomedicines8040094","article-title":"Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the pharmacokinetic parameters of 10 CYP3A substrates","volume":"8","author":"Saiz-Rodr\u00edguez","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0011","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/bcp.12747","article-title":"Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients","volume":"80","author":"Monostory","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0012","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/jpet.111.189597","article-title":"Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression","volume":"341","author":"Temesv\u00e1ri","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0013","series-title":"Envarsus\u202f: EPAR - Product Information","year":"2022"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0014","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3389\/fphar.2020.01218","article-title":"CYP3A5 gene-guided tacrolimus treatment of living-donor Egyptian kidney transplanted patients","volume":"11","author":"Mendrinou","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/dmpt-2016-0036","article-title":"Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients","volume":"32","author":"Tamashiro","year":"2017","journal-title":"Drug Metab Pers Ther"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0016","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/ajt.13059","article-title":"Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations","volume":"15","author":"Pallet","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.10.046_bib0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/FPC.0b013e32835fcbb6","article-title":"Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis","volume":"23","author":"Zuo","year":"2013","journal-title":"Pharmacogenet Genomics"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522007163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522007163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:43:50Z","timestamp":1758577430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522007163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0041134522007163"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.10.046","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.10.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}